Medigen, BlueWillow collaborate to develop SARS-CoV-2 intranasal vaccine

Medigen, BlueWillow collaborate to develop SARS-CoV-2 intranasal vaccine

Submitted by admin on November 11, 2020 - 10:56am
Source: 
Pharmaceutical Business Review
News Tags: 
Medigen
BlueWillow Biologics
intranasal vaccines
vaccines
COVID-19
Headline: 
Medigen, BlueWillow collaborate to develop SARS-CoV-2 intranasal vaccine
snippet: 

Medigen Vaccine Biologics (MVC) has collaborated with BlueWillow Biologics for the development of intranasal vaccine for SARS-CoV-2, the novel coronavirus responsible for Covid-19 disease.

Do Not Allow Advertisers to Use My Personal information